Cooley: Alethio Therapeutics Announces $90 Million Series A
November 06, 2026
November 06, 2026
PALO ALTO, California, Nov. 6 -- Cooley, a law firm, issued the following news release:
* * *
Alethio Therapeutics Announces $90 Million Series A
London November 5, 2026
Cooley advised Alethio Therapeutics, a biopharmaceutical company developing next-generation therapies for myeloproliferative neoplasms, on its $90 million Series A.
Lawyers Tom Goodman, Joe Sandys, Ellen Dewhurst and Alexandra Paterson led the Cooley team advising . . .
* * *
Alethio Therapeutics Announces $90 Million Series A
London November 5, 2026
Cooley advised Alethio Therapeutics, a biopharmaceutical company developing next-generation therapies for myeloproliferative neoplasms, on its $90 million Series A.
Lawyers Tom Goodman, Joe Sandys, Ellen Dewhurst and Alexandra Paterson led the Cooley team advising . . .